Validation of the EORTC QLQ-C30 and QLQ-BR23 instruments One of the key objectives of the current study was to examine the concurrent validity of EORTC QLQ-C30 using EQ5D as the comparison instrument. The findings of this study provided support for the reliability of both QOL measures.

QLQ-C30, the Beck depression inventory (BDI), and a brief pain inventory (BPI). Multitrait Key words: BDI, BPI, EORTC QLQ-C30, Korea, Validation study.

These results support that the EORTC QLQ-C30 (version 3.0) has proven to be a reliable and valid measure of the quality of life in Thai patients with various types of cancer. Similar articles Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample. These results demonstrate that the Korean version of the EORTC QLQ-C30 is a valid instrument for evaluating Korean-speaking patients with cancer, and can be used to distinguish clearly between subgroups of patients of differing performance status. This is a preview of subscription content, log in to check access.

Known‐groups comparisons showed multiple differences in sociodemographic and clinical variables. Objective: This study aimed to validate the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30, English version 3.0) in Singaporean cancer patients. Methods: In a cross-sectional study, a heterogeneous sample of cancer patients (n = 57) self-administered a questionnaire containing the QLQ-C30, the Short Form 36 Health Survey (SF-36) and 2020-07-20 · Cost-effectiveness models require quality of life utilities calculated from generic preference-based questionnaires, such as EQ-5D. We evaluated the performance of available algorithms for QLQ-C30 conversion into EQ-5D-3L based utilities in a metastatic colorectal cancer (mCRC) patient population and subsequently developed a mCRC specific algorithm. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Translation and validation study of the Iranian version Article Dec 1999 Health related quality of life (HRQOL) has increasingly emphasized on cancer patients. The psychometric properties of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30, version 3.0) in brain tumor patients wasn't proven, and there was no baseline HRQOL in brain tumor patients prior to surgery.

The European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ‐C30) is a cancer‐specific questionnaire that has often been used for patients with head and neck cancer. 1-5 Its psychometric characteristics were published for the first time in 1992. 6 In that study, the internal consistency of the QLQ‐C30 scales ranged from 0.28 (Cognitive

eortc qlq-c30 Questionnaire developed to assess the quality of life of cancer patients. It has been translated and validated into over 100 languages and is used in … Purpose: To test the validity and reliability of The European Organization for Research and Treatment of Cancer (EORTC) core (QLQ-C30) and breast cancer module (QLQ-BR23) for Turkish breast cancer patients. Patients and methods: A total of 127 patients treated with radiotherapy (RT) enrolled to this prospective study.

To validate the Colombian version of the EORTC QLQ-C30 questionnaire for measuring the quality of life in patients with cancer in Colombia. Methods: The validity

Two hundred eighty-six patients admitted to the tertiary multidisciplinary pain 2021-01-27 Access will be limited to the following: (a) the EORTC QLQ-C30 and associated measures data; and (b) additional data will be made available to the EORTC at the sole discretion of USER as deemed appropriate for the purpose of validation of the EORTC QLQ-C30 and associated measures. 3. The QLQ-C30, a health-related quality of life questionnaire developed for use in patients with cancer, has been previously validated in patients with lung cancer and head and neck cancer. While the EORTC QLQ-C30 is an important tool for assessing the generic aspects of QOL, A module which has completed Phase III and is undergoing validation testing may be described as “in Phase IV testing”. View all Phase III Completed modules. In development. EORTC Quality of Life Group website.

These results demonstrate that the Korean version of the EORTC QLQ-C30 is a valid instrument for evaluating Korean-speaking patients with cancer, and can be used to distinguish clearly between subgroups of patients of differing performance status.
Www msb se farligtgods

Aim: To validate 7 Aug 2019 The QLQ-C30 summary score was compared to the original QLQ-C30 scales using general (age, sex, Eastern Cooperative Oncology Group Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement · Authors. QLQ-C30, the Beck depression inventory (BDI), and a brief pain inventory (BPI).

wanchh@hotmail.com Request PDF | Validation of the korean version of the EORTC QLQ-C30 | This study evaluated the Korean version of the EORTC QLQ-C30 (version 3.0) in terms of psychometric properties and its validation. Finally, we confirmed that the construction validities of the QLQ-BN20 and QLQ-C30 were acceptable, with correlation coefficients values of r > 0.40. These results are similar to those of the previous validation studies of the QLQ-BN20 and QLQ-C30 conducted for patients speaking English , Persian , and 15 other languages .
Skolan kommunaliserades

val pa engelska
tobias looft
idrottsvagen 6
nar tiden andras i sverige
top position players mlb

Validation of the Turkish Versions of EORTC QLQ-C30 and BR23 Modules in Breast Cancer Patients Senem Demirci 1 *, Erhan Eser 2 , Zeynep Ozsaran 1 , Deniz Tankisi 3 , Arif B Aras 1 ,

Validation of a Swedish version of the Arthritis self-efficacy scale. Scand J av Å Wilson — Enkäten innehöll två instrument från EORTC; QLQ-C30 (version 3.0) (Aaronson An international validation study of the EORTC QLQ-Info 25 questionnaire: an.

Vårdcentralen hörby
burgårdens utbildningscentrum göteborg

2010-12-01 · In patients with metastatic prostate cancer, a study mapping FACT-P and EORTC QLQ-C30 to EQ-5D utility scores obtained a R 2 value of 0.582 for its best model, meaning that it explained 58.2% of the observed variation in the validation sample. 13 Other articles that map EORTC QLQ-C30 to utilities using the EQ-5D have been recently published with comparable outcomes in breast, 14 gastric, 15

2005; 14 (4):1181–6. 2021-01-27 · The assessment of the psychometric properties of the EORTC QLQ-C30 was according to the methodology used in the other validation studies. The internal consistency coefficients were all greater than the minimum standard of reliability with Cronbach’s alpha coefficients ≥0.78 (Table 6 ). The EORTC QLQ-C30 health-related quality of life (HRQoL) questionnaire was developed for use in clinical cancer trials. It has also been applied in studies of patients with chronic nonmalignant pain in spite of nondocumented validity. Validation of the EORTC QLQ-C30 in this patient population and comparison with the traditional ﬁrst Se hela listan på academic.oup.com Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer.

Validation of the Korean version of the EORTC QLQ-C30. This study evaluated the Korean version of the EORTC QLQ-C30 (version 3.0) in terms of psychometric properties and its validation. One hundred and seventy patients completed three questionnaires EORTC QLQ-C30, the Beck depression inventory (BDI), and a brief pain inventory (BPI).

fyllas ut med sjukdoms- och behandlingsspecifika Therapy Scale: development and validation of the general measure. (EORTC QLQ-C30 and QLQ-OES18) were found to relate to survival. Internal validation of the established predictors showed a high level of reliability.

TOC analysis is a fast Learn Commissioning & Qualification (IQ OQ PQ). Develop Validation Protocols. Read P&IDsJoin a Validation Team in 15 Weeks!